Haleon buys back 4.49M shares on October 29-30

The post-settlement voting-rights count is 8,792,102,866, which Haleon says shareholders may use to assess FCA interest-notification requirements.

Available on EDGAR 11/02/2026 - 06:23 AM EST Accepted by SEC EDGAR 11/02/2026 - 06:22 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Haleon plc (HLN) purchased 4,492,636 ordinary shares under its share buyback programme announced on October 29, 2026, to be held as treasury shares. Purchases were made on October 29 and 30, 2026. After settlement, the company had 8,808,341,409 ordinary shares of £0.01 each in registered share capital, of which 16,238,543 were held as treasury shares; 8,792,102,866 ordinary shares had voting rights.

Key Figures

Shares purchased: 4,492,636 ordinary shares Shares purchased: 2,170,000 shares Volume weighted average price: 318.23p per share +4 more

7 metrics

Shares purchased 4,492,636 ordinary shares Under the share buyback programme; to be held as treasury shares

Shares purchased 2,170,000 shares October 29, 2026

Volume weighted average price 318.23p per share Purchases on October 29, 2026

Shares purchased 2,322,636 shares October 30, 2026

Volume weighted average price 322.97p per share Purchases on October 30, 2026

Treasury shares 16,238,543 shares Following settlement

Ordinary shares with voting rights 8,792,102,866 shares Following settlement

Key Terms

treasury shares, volume weighted average price, registered share capital, Disclosure Guidance and Transparency Rules

4 terms

treasury shares financial

"to be held as treasury shares"

Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.

volume weighted average price financial

"Volume weighted average price paid per Share"

The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.

registered share capital financial

"the Company's registered share capital"

Disclosure Guidance and Transparency Rules regulatory

"the FCA's Disclosure Guidance and Transparency Rules"

Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did HLN buy back?

Haleon purchased 4,492,636 ordinary shares to be held as treasury shares. The purchases took place on October 29 and 30, 2026.

What prices did HLN pay for the shares?

For purchases on October 29, 2026, the volume weighted average price was 318.23p per share. For purchases on October 30, 2026, it was 322.97p per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2026

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	02 November 2026 - “Transactions in Own Shares”

99.1

Haleon plc: Aggregated information - transactions in own shares

02 November 2026: Haleon plc (the “Company” or “Haleon”) today announces the purchase of 4,492,636 ordinary shares of £0.01 each in the Company (the “Shares”) to be held as treasury shares under its share buyback programme announced on 29 October 2026.

	London Stock Exchange	CBOE (UK)/BXE	CBOE (UK)/CXE	Aquis
Date of purchase:	29 October 2026
Number of Shares purchased:	2,170,000	-	-	-
Highest price paid per Share (p):	334.00p	-	-	-
Lowest price paid per Share (p):	310.60p	-	-	-
Volume weighted average price paid per Share (p):	318.23p	-	-	-
Date of purchase:	30 October 2026
Number of Shares purchased:	2,322,636	-	-	-
Highest price paid per Share (p):	326.60p	-	-	-
Lowest price paid per Share (p):	320.10p	-	-	-
Volume weighted average price paid per Share (p):	322.97p	-	-	-

Following the settlement of the above, the Company's registered share capital is 8,808,341,409 ordinary shares of £0.01 each, of which 16,238,543 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,792,102,866 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/3013B_1-2026-11-1.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.

Enquiries

Investors		Media
Jo Russell	+44 7787 392441	Zoë Bird	+44 7736 746167
Rakesh Patel	+44 7552 484646	Victoria Durman	+44 7894 505730
Email: investor-relations@haleon.com		Email: corporate.media@haleon.com

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit www.haleon.com. 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: November 02, 2026	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary